bluedoor data·H-1B Jobs API·bluedoor.sh ->

Home / Companies / Glycan Therapeutics Llc / Trends

Glycan Therapeutics Llc H-1B trends

Quarterly LCA aggregate trend points for Glycan Therapeutics Llc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.

Summary

H-1B LCA filings for Glycan Therapeutics Llc span 2019 Q2 to 2021 Q3, peaking at 2 filings in 2020 Q2.

The most recent reported period (2021 Q3) shows 2 filings.

LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.

PeriodLCA countRole titlesSOC codesAvg wage lowAvg prevailingCertifiedCertification rate
2019 Q2111$75,000$72,8211100.0%
2020 Q2222$70,160$67,9232100.0%
2021 Q2221$80,000$73,6322100.0%
2021 Q3221$80,000$73,6322100.0%

Frequently asked questions

How have H-1B filings for Glycan Therapeutics Llc changed over time?
H-1B LCA filings for Glycan Therapeutics Llc span 2019 Q2 to 2021 Q3, peaking at 2 filings in 2020 Q2. The most recent reported period (2021 Q3) shows 2 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API

Rendered from the bluedoor H-1B Jobs API. Reproduce it:

GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=glycan+therapeutics+llc&metric=lca_countJSON